Equities

Caroline Simmons, deputy head of UK investment office at UBS Wealth Management, analyses which FTSE companies are on target to meet and miss their Q2 earnings expectations.

Subject to regulatory approval

'High risk' event for emerging markets

Long term uncertainty reigns

Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.

Three countries gaining momentum

Index 'substantially' below all-time peak

Falling commodities weaken sentiment

Showing signs of strength

The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.